Literature DB >> 28438060

Perceptions of a multidisciplinary team regarding a pediatric rehabilitation modified needs assessment.

Jannick Lavigne1,2, Paula W Rushton1,2, Nathalie Trudelle3.   

Abstract

BACKGROUND: Efficient service delivery models that optimize processes and human resources are required in the current health care climate. A family-centered care approach is recognized as a model that can improve the effectiveness and efficiency of pediatric rehabilitation. The objective of this study was to explore the perceptions of a multidisciplinary health care team regarding the use of the Préparation au plan d'intervention (PAPI), a modified needs assessment tool designed to facilitate a family-centered care approach among children with cerebral motor deficits (CMD) and their families.
METHODS: One focus group was conducted with the multidisciplinary team (n = 10) of the CMD program at a pediatric rehabilitation center. It was audio recorded and transcribed verbatim for content analysis.
RESULTS: Three overarching themes were identified from the analyzes: (1) a facilitator of open communication, (2) a way to gain the unique sense of the child and family and (3) parents as the experts of their child.
CONCLUSIONS: Health care professionals value the use of the PAPI as a way of facilitating a family-centered care plan process, specifically with children with cerebral motor deficits.

Entities:  

Keywords:  Evaluation; family-centered care approach; focus group; pediatric intervention

Mesh:

Year:  2017        PMID: 28438060     DOI: 10.1080/11038128.2017.1320584

Source DB:  PubMed          Journal:  Scand J Occup Ther        ISSN: 1103-8128            Impact factor:   2.611


  1 in total

1.  Role, function and challenges of multidisciplinary centres for rare diseases exemplified for neurofibromatosis type 1 syndrome.

Authors:  Hagit Toledano-Alhadef; Victor-Felix Mautner; Isabel Gugel; Julian Zipfel; Karin Haas-Lude; Shlomi Constantini; Martin U Schuhmann
Journal:  Childs Nerv Syst       Date:  2020-06-08       Impact factor: 1.475

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.